Supermarkets are selling more eggs. Gyms are getting rid of cardio machines to make more room for free weights. And cosmetic clinics are seeing a lot of “Ozempic face”. It’s estimated about ...

GDANSK/LONDON (Reuters) - Bank of America analysts on Friday said Novo Nordisk (NYSE:NVO) may miss first-quarter expectations, as sales of its blockbuster Wegovy and Ozempic drugs lag, which could ...

GDANSK/LONDON (Reuters) - Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy and Ozempic drugs lag, which could prompt the ...

Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...

Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as ...

In the latest Good Buy or Goodbye, Regan Capital chief investment officer Skyler Weinand joins Market Domination host Julie Hyman to break down which stock is a good buy and what stock should be ...

In the latest Good Buy or Goodbye, Regan Capital chief investment officer Skyler Weinand joins Market Domination host Julie Hyman to break down which stock is a good buy and what stock should be ...

As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...

Perez Hilton has struggled with weight management for decades. Now, he’s spreading the word about the benefits of GLP-1 drugs ...